跳到主要內容

Thompson Peter A. 的 Form 4 申報

ARS Pharmaceuticals, Inc.(SPRY),2024/8/23 申報

申報編號
0000947871-24-000721
申報時間
2024/8/23
交易日
2024/8/21-8/23
申報延遲
2 天
10b5-1 計畫
沒有勾選

這份申報列了 4 筆非衍生性交易。公開市場賣出合計 $1,150 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Thompson Peter A.CIK 0001357522董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2024/8/21Common StockS賣出處分−394,400$13.52F1−$5,332,288557,977間接
2024/8/21Common StockS賣出處分−13,300$14.61F2−$194,313544,677間接
2024/8/22Common StockS賣出處分−391,482$12.94F3−$5,065,777.08153,195間接
2024/8/23Common StockS賣出處分−69,500$13.03F4−$905,58583,695間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

Represents the weighted average sale price of the shares of the Issuer's common stock sold, ranging from a low of $13.30 to a high of $13.925 per share. The Reporting Person undertakes, upon request by the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F2

Represents the weighted average sale price of the shares of the Issuer's common stock sold, ranging from a low of $14.605 to a high of $14.615 per share. The Reporting Person undertakes, upon request by the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents the weighted average sale price of the shares of the Issuer's common stock sold, ranging from a low of $12.765 to a high of $13.475 per share. The Reporting Person undertakes, upon request by the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents the weighted average sale price of the shares of the Issuer's common stock sold, ranging from a low of $12.80 to a high of $13.20 per share. The Reporting Person undertakes, upon request by the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)